PLEASANTON, Calif - Thoratec Laboratories Corporation has announced that it will purchase Thermo Cardiosystmes, Inc. for $572 million in newly issued stock. Under the new deal, which is expected to close next year, Thoratec will exchange .835 a newly issued share for each share of Thermo Cardiosystems. Both companies are manufacturers of artificial heart devices. For more information visit www.thoratec.com.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.